MIF and non-small cell lung carcinoma: In vitro, cisplatin-resistant NSCLC cell lines (A549R, H460R) exhibit elevated self-renewal capacity and release macrophage migration inhibitory factor (MIF), which skews macrophages toward an M2 phenotype and fosters metastatic progression (96).